ReviewCureus2023

Comparison of Effectiveness and Safety of Ustekinumab and Adalimumab As Induction or Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis.

Venkata Sai Harshabhargav Chenna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.